| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |